524602 — Bandaram Pharma Packtech Income Statement
0.000.00%
Last trade - 00:00Basic MaterialsSpeculativeMicro Cap
- IN₹399.48m
- IN₹458.15m
- IN₹187.32m
Annual income statement for Bandaram Pharma Packtech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 0 | 0 | 187 |
| Cost of Revenue | |||
| Gross Profit | 0 | 0 | 26.8 |
| Selling / General / Administrative Expenses | |||
| Depreciation and Amortization | |||
| Unusual Expense / Income | |||
| Other Operating Expenses | |||
| Total Operating Expenses | 0.316 | 0.1 | 180 |
| Operating Profit | -0.316 | -0.1 | 7.58 |
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | -0.316 | -0.101 | 3.26 |
| Provision for Income Taxes | |||
| Net Income After Taxes | -0.316 | -0.101 | 2.58 |
| Minority Interest | |||
| Net Income Before Extraordinary Items | |||
| Net Income | -0.316 | -0.101 | 1.42 |
| Adjustments to Net Income | |||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | -0.316 | -0.101 | 1.42 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | -0.048 | -0.012 | 0.164 |
| Dividends per Share |